Interestingly, although cancer cells with the BRAFV600E mutation are addictive to the MEK–ERK signaling for survival, BEZ235 could further offer additive or synergistic effects with the toxin, suggesting that PI3K pathways may also contribute to survival of these cells. Here, MAP2K7 is linked to cancer.